|
Scientific development and product improvement must rely on testing and feedback from objective third party scientists. Following are several of the leading cognitive function researchers with a broad base of clinical experience. Brain Research Labs is proud to have such “brain power” involved in testing, validating and improving its products and technology.
 Con Stough, Ph.D., Director of the Brain Sciences Institute
The clinical trial on Procera-AVH™ was conducted by Dr. Con Stough of the prestigious Brain Sciences Institute, Swinburne University of Technology, in Australia. Dr. Stough has published over 100 papers in peer reviewed journals.
The Brain Sciences Institute (BSI) is one of the leading cognitive supplement test labs in the world. The principal aim of the Brain Sciences Institute (BSI) is to conduct high quality research in human neuro and cognitive sciences. This is accomplished with a multi-disciplinary team of researchers across several different disciplines and areas of expertise that include physicists, psychologists, psycho-physiologists, biophysicists and neuroscientists.
Under the direction of Dr. Stough, BSI has conducted clinical trials on a broad array of pharmaceutical drugs and nutritional supplements, using one of the most advanced, fully equipped neuro and cognitive science labs in the world.
Equipment and capabilities include expensive and state-of-the-art brain imaging machines, such as MRI, fMRI and MEG, electrical recordings, EEG and ERP, lab blood analysis of sensitive markers of oxidative stress and aging, and neuro-psychological measures including the world’s most advanced and respected cognitive assessment technology from CDR (Cognitive Drug Research), used in 100s of clinical trials for multi-national pharmaceutical companies.
The staff at the BSI have an international research reputation in several areas: Clinical Psychology and Trauma; Brain Electrical Neuroimaging; Biological Basis of Intelligence and Psychological Assessment; Visual Disorders and Processes; the Human Health Effects of Mobile Phone Emissions; Illicit Drug Research; Emotional Intelligence; and Clinical Trials on Natural Pharmacological Compounds. In addition the Centre will continues to build a significant domestic and international research presence in multi-disciplinary areas relating to Biological and Clinical Psychology, Cognitive Neuroscience and Biological Psychiatry.
 Keith Wesnes, Ph.D, president and founder of Cognitive Drug Research (CDR) in England.
Dr. Wesnes has conducted over 500 cognitive clinical trials and written over 200 papers in peer reviewed journals.
The Cognitive Drug Research (CDR) cognitive tests were used to validate the positive effects of Procera-AVH™ in working memory and memory speed over 30 days usage in over 100 normal, healthy individuals, age 18-65.
CDR is the world’s leading provider of cognitive testing services for the pharmaceutical industry. The CDR computerized test battery is perhaps the most sensitive and comprehensive way to detect and quantify drug and nutraceutical induced changes in a broad range of cognitive parameters including alertness, attention (concentration), cognition (e.g., decision making), working memory and memory.
The CDR system is a simple to administer automated test system which can definitively identify either enhancements or impairments to cognitive function in any population in any clinical trial setting.
CDR is based in Goring-on-Thames, UK with easy rail, road and air access. CDR has just incorporated in the United States and currently has offices in Chicago. The CDR system has been used in well over one thousand sites worldwide at every stage of drug development. The system has been used to evaluate cognitive function in every type of Phase I trial in more than 100 Units throughout the US and Europe.
CDR’s unparalleled resource capacity together with its easily applied automated system ensure that customized cognition assessments can be prepared and implemented into any trial design to virtually any timeline.
 Andrea Zangara, PhD, Scientific Business Development Northumbria University, Newcastle-upon-Tyne, England, and former Research Manager of the university’s prestigious Human Cognitive Neuroscience Unit.
Andrea Zangara and the state-of-the-art cognitive test laboratory at Northumbria University have independently studied and verified the safety and efficacy of a host of pharmaceutical as well as natural cognitive-enhancing substances, such as found in Procera-AVH.
Dr. Zangara has recently completed a comprehensive reference book entitled, Education For a Healthy Diet and Guide to the Use of Food Supplements. Dr. Zangara has conducted and published numerous studies on nutraceuticals and their effects cognitive function.
Dr. Zangara will keep Brain Research Lab’s researchers aware of subsequent new scientific insights into Procera-AVH ingredient effects and mechanisms of action, as well new discoveries of breakthrough nutritional ingredients, such as, herbs and spices for enhanced brain health and cognitive performance.
|
